Panel Discussion: Debating the Best Approach to Target TGF-ß

Time: 10:45 am
day: Day One

Details:

• Which TGF-ß isoform to target to maximize therapeutic potential in IO and minimize adverse risk
• Combination approaches vs monotherapy?
• Is there one therapeutic approach with greater potential than others?

Speakers: